These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9870897)

  • 41. Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor.
    Joseph K; Tholanikunnel BG; Kaplan AP
    J Allergy Clin Immunol; 2009 Jul; 124(1):143-9. PubMed ID: 19342086
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of kininogen expression during distal nephron differentiation.
    El-Dahr SS; Dipp S; Yosipiv IV; Carbini LA
    Am J Physiol; 1998 Jul; 275(1):F173-82. PubMed ID: 9689019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tissue-Specific expression of rat kininogen mRNAs.
    Takano M; Sakanaka F; Yayama K; Okamoto H
    Biol Pharm Bull; 2000 Oct; 23(10):1239-42. PubMed ID: 11041259
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Demonstration of derivation of rat urinary bradykinin from plasma low-molecular-weight kininogen: a study using kininogen-deficient rats.
    Hagiwara Y; Kojima M; Hayashi I; Oh-ishi S
    Biochem Biophys Res Commun; 1994 Nov; 204(3):1219-24. PubMed ID: 7980599
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Commercial immunodepleted deficient plasmas contain cleaved high molecular weight kininogen (HK).
    Mannhalter C; Lang H
    Thromb Haemost; 1988 Dec; 60(3):447-52. PubMed ID: 3238647
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine factor XII: interaction of HMW kininogen with kaolin and plasma prekallikrein.
    Ikari N; Sugo T; Fujii S; Kato H; Iwanaga S
    J Biochem; 1981 Jun; 89(6):1699-709. PubMed ID: 6912861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of kininogens in human malignant ascites.
    Karlsrud TS; Buø L; Aasen AO; Johansen HT
    Thromb Res; 1991 Sep; 63(6):641-50. PubMed ID: 1780808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kininogen changes in human plasma following a test meal or insulin administration.
    Rothschild AM; Boden G; Colman RW
    Am J Physiol; 1996 Mar; 270(3 Pt 2):H1071-7. PubMed ID: 8780205
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure and expression of two kininogen genes in mice.
    Cardoso CC; Garrett T; Cayla C; Meneton P; Pesquero JB; Bader M
    Biol Chem; 2004; 385(3-4):295-301. PubMed ID: 15134344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A different cleavage site for high molecular weight kininogen in vivo following intravenous injection of dextran sulfate in the rabbit.
    Wiggins RC
    Circ Res; 1986 Apr; 58(4):595-604. PubMed ID: 2421941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absorption of kininogen from human plasma by Streptococcus pyogenes is followed by the release of bradykinin.
    Ben Nasr A; Herwald H; Sjöbring U; Renné T; Müller-Esterl W; Björck L
    Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):657-60. PubMed ID: 9307013
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kininogen expression by rat vascular smooth muscle cells: stimulation by lipopolysaccharide and angiotensin II.
    Okamoto H; Yayama K; Shibata H; Nagaoka M; Takano M
    Biochim Biophys Acta; 1998 Sep; 1404(3):329-37. PubMed ID: 9739161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of molecular defects of Fitzgerald trait and another novel high-molecular-weight kininogen-deficient patient: insights into structural requirements for kininogen expression.
    Krijanovski Y; Proulle V; Mahdi F; Dreyfus M; Müller-Esterl W; Schmaier AH
    Blood; 2003 Jun; 101(11):4430-6. PubMed ID: 12576314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The hyaluronan-binding serine protease from human plasma cleaves HMW and LMW kininogen and releases bradykinin.
    Etscheid M; Beer N; Fink E; Seitz R; Johannes D
    Biol Chem; 2002 Oct; 383(10):1633-43. PubMed ID: 12452440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelet thrombospondin interactions with human high and low molecular weight kininogens.
    DeLa Cadena RA; Wyshock EG; Kunapuli SP; Schultze RL; Miller M; Walz DA; Colman RW
    Thromb Haemost; 1994 Jul; 72(1):125-31. PubMed ID: 7974360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two faces of high-molecular-weight kininogen (HK) in angiogenesis: bradykinin turns it on and cleaved HK (HKa) turns it off.
    Guo YL; Colman RW
    J Thromb Haemost; 2005 Apr; 3(4):670-6. PubMed ID: 15733059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunovisualization of high (HK) and low (LK) molecular weight kininogens on isolated human neutrophils.
    Figueroa CD; Henderson LM; Kaufmann J; De La Cadena RA; Colman RW; Müller-Esterl W; Bhoola KD
    Blood; 1992 Feb; 79(3):754-9. PubMed ID: 1732013
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Attenuated kinin release from human neutrophil elastase-pretreated kininogens by tissue and plasma kallikreins.
    Dulinski R; Suder P; Guevara-Lora I; Rapała-Kozik M; Potempa J; Silberring J; Imamura T; Travis J; Kozik A
    Biol Chem; 2003 Jun; 384(6):929-37. PubMed ID: 12887060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contiguous binding and inhibitory sites on kininogens required for the inhibition of platelet calpain.
    Bradford HN; Jameson BA; Adam AA; Wassell RP; Colman RW
    J Biol Chem; 1993 Dec; 268(35):26546-51. PubMed ID: 8253784
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.